Rhabdomyosarcoma in childhood and adolescence
Read Online

Rhabdomyosarcoma in childhood and adolescence

  • 914 Want to read
  • ·
  • 3 Currently reading

Published by Year Book Medical Publishers in Chicago .
Written in English


  • Rhabdomyosarcoma.,
  • Tumors in children.,
  • Tumors in adolescence.

Book details:

Edition Notes

Includes bibliographical references.

StatementHarold M. Maurer ... [et al.].
SeriesCurrent problems in cancer ;, v. 2, no. 9
LC ClassificationsRC280.M8 M38
The Physical Object
Pagination36 p. :
Number of Pages36
ID Numbers
Open LibraryOL4765674M
ISBN 10081519918X
LC Control Number78113044

Download Rhabdomyosarcoma in childhood and adolescence


  Europe PMC is an ELIXIR Core Data Resource Learn more >. Europe PMC is a service of the Europe PMC Funders' Group, in partnership with the European Bioinformatics Institute; and in cooperation with the National Center for Biotechnology Information at the U.S. National Library of Medicine (NCBI/NLM).It includes content provided to the PMC International archive by participating   e Background: Rhabdomyosarcoma is a rare tumor in children and adolescents, presenting 3% to 4% of all pediatric cancers. The female genital tract is considered as a favorable site of childhood RMS. The outcome has improved significantly during the last two decades, attributed to risk stratification and multimodality management of these challenging :// A bimodal age peak for ERMS was observed, with the second, smaller peak in adolescence noted for males only; ARMS incidence did not vary by age or sex. Five‐year survival rates for RMS and ERMS increased during the period from to (% and %, respectively) to the period from to (% and %, respectively), whereas Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89 J Clin Oncol. Apr 20;23(12) doi: /JCO Epub Feb Authors

  (See "Rhabdomyosarcoma in childhood and adolescence: Epidemiology, pathology, and molecular pathogenesis" and "Rhabdomyosarcoma in childhood and adolescence: Clinical presentation, diagnostic evaluation, and staging".) TREATMENT IN CHILDHOOD AND ADOLESCENCE. Overview of risk-adapted therapy — In the past, fewer than 20 percent of patients Survival rates among children with rhabdomyosarcoma have increased from approximately 20% to 70% during the past 15 years, and this improvement appears to be progressive. The major factor in this remarkable development has been the increasing effectiveness of multiple-agent, long-range chemotherapy regimens in (a) destroying micrometastasis, (b) controlling residual tumor at the sites of   Medline ® Abstracts for References of 'Rhabdomyosarcoma in childhood, adolescence, and adulthood: Treatment' 1 Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, , National Cancer ://   {{scription}}

Epidemiology and etiology. Rhabdomyosarcoma accounts for 7% of malignant tumors in children and is the most frequent soft tissue sarcoma in children [].According to American data new cases of RMS are registered each year in the United States [].Onset of the disease is at 2–5 years of ://   Stevens MC, Rey A, Bouvet N, et al. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor J Clin Oncol ; Months SR, Raney RB. Rhabdomyosarcoma of the head and neck in children: the experience at the Children's In contrast, ARMS is distributed more evenly throughout childhood and adolescence (half of the cases occur after age 10 years) and has different primary sites than ERMS. 1 Translocations t(2;13) and t(1;13) often are observed in ARMS, whereas allelic loss on chromosome 11 is frequent in :// Rhabdomyosarcoma of the parotid region occurring in childhood and adolescence